JP2009528296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528296A5 JP2009528296A5 JP2008556582A JP2008556582A JP2009528296A5 JP 2009528296 A5 JP2009528296 A5 JP 2009528296A5 JP 2008556582 A JP2008556582 A JP 2008556582A JP 2008556582 A JP2008556582 A JP 2008556582A JP 2009528296 A5 JP2009528296 A5 JP 2009528296A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- ylamino
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 41
- -1 propargyl compound Chemical class 0.000 claims description 15
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- 150000003935 benzaldehydes Chemical class 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 238000006268 reductive amination reaction Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- JJOWVQRSSFANTK-QHCPKHFHSA-N (2s)-2-[[2-(diethylamino)-5-[ethyl(2-methylpropylsulfonyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(CC)S(=O)(=O)CC(C)C)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 JJOWVQRSSFANTK-QHCPKHFHSA-N 0.000 claims 1
- LLYUGVGQHYKTPB-NRFANRHFSA-N (2s)-2-[[2-(diethylamino)-5-[ethyl(3,3,3-trifluoropropylsulfonyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(CC)S(=O)(=O)CCC(F)(F)F)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 LLYUGVGQHYKTPB-NRFANRHFSA-N 0.000 claims 1
- WQRWVWWUVJMCFW-FQEVSTJZSA-N (2s)-2-[[2-(diethylamino)-5-[ethyl(methylsulfonyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(CC)S(C)(=O)=O)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 WQRWVWWUVJMCFW-FQEVSTJZSA-N 0.000 claims 1
- GWHSRLXGMCCAIN-QFIPXVFZSA-N (2s)-2-[[2-(diethylamino)-5-[ethyl(propylsulfonyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCCS(=O)(=O)N(CC)C1=CN=C(N(CC)CC)N=C1N[C@H](C(O)=O)CC(C=C1)=CC=C1OC(=O)N1CCCC1 GWHSRLXGMCCAIN-QFIPXVFZSA-N 0.000 claims 1
- DFGIRJIXSZXHRL-IBGZPJMESA-N (2s)-2-[[2-(diethylamino)-5-[methyl(methylsulfonyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(C)S(C)(=O)=O)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 DFGIRJIXSZXHRL-IBGZPJMESA-N 0.000 claims 1
- GDLQGBLMGXDNRQ-NRFANRHFSA-N (2s)-2-[[2-(diethylamino)-5-[methylsulfonyl(prop-2-ynyl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(CC#C)S(C)(=O)=O)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 GDLQGBLMGXDNRQ-NRFANRHFSA-N 0.000 claims 1
- SDRNIMLNYYTUKR-NRFANRHFSA-N (2s)-2-[[2-(diethylamino)-5-[methylsulfonyl(propan-2-yl)amino]pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(C(C)C)S(C)(=O)=O)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 SDRNIMLNYYTUKR-NRFANRHFSA-N 0.000 claims 1
- UIUBHENCCNLCKN-QFIPXVFZSA-N (2s)-2-[[5-[3-chloropropylsulfonyl(ethyl)amino]-2-(diethylamino)pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(CC)S(=O)(=O)CCCCl)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 UIUBHENCCNLCKN-QFIPXVFZSA-N 0.000 claims 1
- MJWZBNGONSQHGU-NRFANRHFSA-N (2s)-2-[[5-[3-chloropropylsulfonyl(methyl)amino]-2-(diethylamino)pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCN(CC)C1=NC=C(N(C)S(=O)(=O)CCCCl)C(N[C@@H](CC=2C=CC(OC(=O)N3CCCC3)=CC=2)C(O)=O)=N1 MJWZBNGONSQHGU-NRFANRHFSA-N 0.000 claims 1
- SWLRXLYNAHKZOI-QHCPKHFHSA-N (2s)-2-[[5-[butylsulfonyl(ethyl)amino]-2-(diethylamino)pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound CCCCS(=O)(=O)N(CC)C1=CN=C(N(CC)CC)N=C1N[C@H](C(O)=O)CC(C=C1)=CC=C1OC(=O)N1CCCC1 SWLRXLYNAHKZOI-QHCPKHFHSA-N 0.000 claims 1
- UJURHSUDCZMQEN-QHCPKHFHSA-N (2s)-2-[[5-[cyclopentyl(methylsulfonyl)amino]-2-(diethylamino)pyrimidin-4-yl]amino]-3-[4-(pyrrolidine-1-carbonyloxy)phenyl]propanoic acid Chemical compound N([C@@H](CC=1C=CC(OC(=O)N2CCCC2)=CC=1)C(O)=O)C1=NC(N(CC)CC)=NC=C1N(S(C)(=O)=O)C1CCCC1 UJURHSUDCZMQEN-QHCPKHFHSA-N 0.000 claims 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000006472 autoimmune response Effects 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000003461 sulfonyl halides Chemical class 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 0 CCN(CC)C(C)N=CC(N(*)S(*)(=O)=O)=C(N)N[C@@](CC(C=CC=C)=C*(C)C(N1CCCC1)=O)C(O)=O Chemical compound CCN(CC)C(C)N=CC(N(*)S(*)(=O)=O)=C(N)N[C@@](CC(C=CC=C)=C*(C)C(N1CCCC1)=O)C(O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77759506P | 2006-02-27 | 2006-02-27 | |
| US60/777,595 | 2006-02-27 | ||
| PCT/US2007/062824 WO2007101165A1 (en) | 2006-02-27 | 2007-02-26 | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528296A JP2009528296A (ja) | 2009-08-06 |
| JP2009528296A5 true JP2009528296A5 (enExample) | 2011-04-07 |
| JP5135235B2 JP5135235B2 (ja) | 2013-02-06 |
Family
ID=38215011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008556582A Expired - Fee Related JP5135235B2 (ja) | 2006-02-27 | 2007-02-26 | Ｖａｌ−４によって媒介される白血球の接着を阻害するピリミジニルスルホンアミド化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7579466B2 (enExample) |
| EP (1) | EP1996559A1 (enExample) |
| JP (1) | JP5135235B2 (enExample) |
| KR (1) | KR20080100271A (enExample) |
| CN (1) | CN101389611B (enExample) |
| AR (1) | AR059671A1 (enExample) |
| AU (1) | AU2007220068B2 (enExample) |
| BR (1) | BRPI0708331A2 (enExample) |
| CA (1) | CA2643838A1 (enExample) |
| EA (1) | EA017110B1 (enExample) |
| EC (1) | ECSP088701A (enExample) |
| IL (1) | IL193425A (enExample) |
| MA (1) | MA30318B1 (enExample) |
| MX (1) | MX2008010988A (enExample) |
| MY (1) | MY151045A (enExample) |
| NO (1) | NO20083743L (enExample) |
| NZ (1) | NZ570679A (enExample) |
| TW (1) | TWI389904B (enExample) |
| WO (1) | WO2007101165A1 (enExample) |
| ZA (1) | ZA200807188B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE455106T1 (de) * | 1999-01-22 | 2010-01-15 | Elan Pharm Inc | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen |
| PT2314621E (pt) * | 2004-05-27 | 2014-06-23 | Crucell Holland Bv | Moléculas de ligação capazes de neutralizar o vírus da raiva, e suas utilizações |
| AU2006297180A1 (en) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| WO2007041270A1 (en) * | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| EP1996559A1 (en) | 2006-02-27 | 2008-12-03 | Elan Pharmaceuticals Inc. | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| HUE047230T2 (hu) * | 2006-02-28 | 2020-04-28 | Biogen Ma Inc | Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei |
| WO2007100763A2 (en) * | 2006-02-28 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| EP4582099A3 (en) * | 2006-03-03 | 2025-10-01 | Biogen MA Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
| CA2708262A1 (en) | 2007-12-07 | 2009-06-18 | Elan Pharmaceuticals, Inc. | Methods and compositions for treating liquid tumors |
| CA2760151A1 (en) * | 2009-04-27 | 2010-11-04 | Elan Pharmaceuticals, Inc. | Pyridinone antagonists of alpha-4 integrins |
| WO2011020874A1 (en) | 2009-08-20 | 2011-02-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
| EP4152004B9 (en) | 2010-01-11 | 2025-04-09 | Biogen MA Inc. | Assay for jc virus antibodies |
| US11287423B2 (en) | 2010-01-11 | 2022-03-29 | Biogen Ma Inc. | Assay for JC virus antibodies |
| LT3575792T (lt) | 2011-05-31 | 2023-03-10 | Biogen Ma Inc. | Pdl rizikos vertinimo būdas |
| WO2014193804A1 (en) | 2013-05-28 | 2014-12-04 | Biogen Idec Ma Inc. | Method of assessing risk of pml |
| EP3551034A1 (en) | 2016-12-07 | 2019-10-16 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| AU2017376801B9 (en) | 2016-12-14 | 2024-08-01 | Bt Bidco, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| ES2987796T3 (es) | 2018-10-30 | 2024-11-18 | Gilead Sciences Inc | Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias |
| ES3003232T3 (en) | 2018-10-30 | 2025-03-10 | Gilead Sciences Inc | Compounds for inhibition of alpha4beta7 integrin |
| CN112969687B (zh) | 2018-10-30 | 2024-08-23 | 吉利德科学公司 | 作为α4β7整合素抑制剂的喹啉衍生物 |
| CA3114240C (en) | 2018-10-30 | 2023-09-05 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
| AU2019383976B2 (en) | 2018-11-19 | 2025-07-03 | Bt Bidco, Inc. | Methods and devices for treating a disease with biotherapeutics |
| CN114222730B (zh) | 2019-08-14 | 2024-09-10 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
| US11707610B2 (en) | 2019-12-13 | 2023-07-25 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| US20240301512A1 (en) | 2021-01-29 | 2024-09-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US742628A (en) * | 1898-03-29 | 1903-10-27 | Robert W Gormly | Feed-circle for circular-knitting machines. |
| US654994A (en) * | 1900-03-27 | 1900-07-31 | Leopold May | Centrifugal machine. |
| DE2525656A1 (de) | 1974-06-19 | 1976-01-15 | Sandoz Ag | Verfahren zur herstellung neuer heterocyclischer verbindungen |
| US4018915A (en) * | 1976-01-05 | 1977-04-19 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4055651A (en) * | 1974-11-08 | 1977-10-25 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4096255A (en) * | 1974-11-08 | 1978-06-20 | Mitsubishi Chemical Industries Limited | N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods |
| US4046876A (en) | 1974-11-08 | 1977-09-06 | Mitsubishi Chemical Industries Limited | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4104392A (en) * | 1974-11-08 | 1978-08-01 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them |
| US4073914A (en) * | 1974-11-08 | 1978-02-14 | Mitsubishi Chemical Industries Limited | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4055636A (en) * | 1974-11-08 | 1977-10-25 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4070457A (en) * | 1974-11-08 | 1978-01-24 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4041156A (en) * | 1974-11-08 | 1977-08-09 | Mitsubishi Chemical Industries Limited | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| JPS5727454B2 (enExample) * | 1975-02-21 | 1982-06-10 | ||
| US4036955A (en) * | 1976-07-22 | 1977-07-19 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4018913A (en) * | 1976-01-14 | 1977-04-19 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| CA1102316A (en) | 1975-12-09 | 1981-06-02 | Shosuke Okamoto | N su2 xx-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| DE2742173A1 (de) * | 1977-09-20 | 1979-03-29 | Bayer Ag | Phenoxy-pyridinyl(pyrimidinyl)-alkanole, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| JPS57153844A (en) * | 1981-03-05 | 1982-09-22 | Sato Co Ltd | Device for printing and pasting label |
| IT1211096B (it) * | 1981-08-20 | 1989-09-29 | Lpb Ist Farm | Pirimidine e s.triazinici adattivita' ipolipidemizzante. |
| US4672065A (en) * | 1982-11-19 | 1987-06-09 | Chevron Research Company | N-substituted phenoxyacetamide fungicides |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4565814A (en) | 1983-01-28 | 1986-01-21 | Sanofi | Pyridazine derivatives having a psychotropic action and compositions |
| JPS59212480A (ja) | 1983-05-17 | 1984-12-01 | Nippon Soda Co Ltd | ピリダジン誘導体及び除草剤 |
| DE3322720A1 (de) * | 1983-06-24 | 1985-01-03 | Chemische Werke Hüls AG, 4370 Marl | Verwendung von in 2-stellung mit (substituierten) aminogruppen substituierten 4-dl-alkylester-(alpha)-alaninyl-6-chlor-s-triazinen als herbizide, insbesondere gegen flughafer |
| US4505910A (en) * | 1983-06-30 | 1985-03-19 | American Home Products Corporation | Amino-pyrimidine derivatives, compositions and use |
| NZ210669A (en) | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| PH22520A (en) * | 1984-11-12 | 1988-10-17 | Yamanouchi Pharma Co Ltd | Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them |
| US4959364A (en) * | 1985-02-04 | 1990-09-25 | G. D. Searle & Co. | Method of treating inflammation, allergy, asthma and proliferative skin disease using heterocyclic amides |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0784424B2 (ja) | 1987-04-15 | 1995-09-13 | 味の素株式会社 | チロシン誘導体及びその用途 |
| EP0330506A3 (en) | 1988-02-26 | 1990-06-20 | Dana Farber Cancer Institute | Vla proteins |
| US5011472A (en) * | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| DE3904931A1 (de) * | 1989-02-17 | 1990-08-23 | Bayer Ag | Pyridyl-substituierte acrylsaeureester |
| US5030644A (en) * | 1989-07-31 | 1991-07-09 | Merck & Co., Inc. | Imidazole compounds and their use as transglutaminase inhibitors |
| US5260210A (en) | 1989-09-27 | 1993-11-09 | Rubin Lee L | Blood-brain barrier model |
| US4992439A (en) * | 1990-02-13 | 1991-02-12 | Bristol-Myers Squibb Company | Pyridazine carboxylic acids and esters |
| FR2679903B1 (fr) | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| DE4108029A1 (de) * | 1991-03-13 | 1992-09-17 | Bayer Ag | Triazinyl-substituierte acrylsaeureester |
| AU1354292A (en) | 1991-03-18 | 1992-10-21 | Pentapharm Ag | Parasubstituted phenylalanine derivates |
| IT1247509B (it) * | 1991-04-19 | 1994-12-17 | Univ Cagliari | Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus |
| US5296486A (en) | 1991-09-24 | 1994-03-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Leukotriene biosynthesis inhibitors |
| WO1993012809A1 (en) | 1991-12-24 | 1993-07-08 | Fred Hutchinson Cancer Research Center | Competitive inhibition of high-avidity alpha4-beta1 receptor using tripeptide ldv |
| JPH07504654A (ja) * | 1992-03-11 | 1995-05-25 | ナルヘックス リミテッド | オキソ及びヒドロキシ置換炭化水素のアミン誘導体 |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| DE4227748A1 (de) * | 1992-08-21 | 1994-02-24 | Bayer Ag | Pyridyloxy-acrylsäureester |
| JP2848232B2 (ja) * | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
| US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
| US5510332A (en) * | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| AU2964295A (en) | 1994-07-11 | 1996-02-09 | Athena Neurosciences, Inc. | Inhibitors of leukocyte adhesion |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
| CZ288178B6 (en) * | 1995-09-29 | 2001-05-16 | Sankyo Co | Milbemycin-5-oxime derivatives substituted in position 13-, and their use |
| DE19536891A1 (de) | 1995-10-04 | 1997-04-10 | Basf Ag | Neue Aminosäurederivate, ihre Herstellung und Verwendung |
| DE19548709A1 (de) | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| US6211333B1 (en) | 1996-06-21 | 2001-04-03 | Takeda Chemical Industries, Ltd. | Method for producing peptides and their salts which have an agonist activity of luteinizing hormone releasing hormones secreted from the hypothalamus |
| DE19654483A1 (de) | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanin-Derivate |
| SK176898A3 (en) | 1996-06-28 | 1999-05-07 | Merck Patent Gmbh | Phenylalamine derivatives as integrin inhibitors |
| DE19629817A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| DE19647317A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Schering Agrevo Gmbh | Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
| DE69733272T2 (de) | 1996-11-22 | 2006-01-26 | Elan Pharmaceuticals, Inc., San Francisco | N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta-amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen |
| AU6264898A (en) | 1997-02-04 | 1998-08-25 | Versicor Inc | Solid phase and combinatorial library syntheses of 3,1-benzoxazine-4-ones |
| DE19713000A1 (de) | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| CA2291778A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| ES2257808T3 (es) | 1997-05-29 | 2006-08-01 | MERCK & CO., INC. (A NEW JERSEY CORP.) | Acidos biarilalcanoicos como inhibidores de adhesion celular. |
| JP2001512134A (ja) | 1997-07-31 | 2001-08-21 | エラン・ファーマシューティカルズ・インコーポレーテッド | Ｖｌａ−４仲介性白血球付着を阻害する置換フェニルアラニン型化合物 |
| AR016133A1 (es) | 1997-07-31 | 2001-06-20 | Wyeth Corp | Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria |
| CN1265669A (zh) | 1997-07-31 | 2000-09-06 | 伊兰药品公司 | 抑制由vla－4介导的白细胞粘着的化合物 |
| PL338373A1 (en) | 1997-07-31 | 2000-10-23 | Elan Pharm Inc | Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4 |
| HU229362B1 (en) | 1997-08-22 | 2013-11-28 | Hoffmann La Roche | N-alkanoylphenylalanine derivatives |
| WO1999010313A1 (en) | 1997-08-22 | 1999-03-04 | F.Hoffmann-La Roche Ag | N-aroylphenylalanine derivatives |
| EP1049665A1 (en) | 1998-01-23 | 2000-11-08 | Novartis AG (Novartis SA) (Novartis Inc.) | Vla-4 antagonists |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| CN1305473A (zh) | 1998-04-16 | 2001-07-25 | 得克萨斯生物技术公司 | 抑制整联蛋白与其受体结合的n,n－二取代的酰胺 |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| AU769741B2 (en) * | 1999-01-22 | 2004-02-05 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| AU2623900A (en) * | 1999-01-22 | 2000-08-07 | American Home Products Corporation | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| ATE455106T1 (de) * | 1999-01-22 | 2010-01-15 | Elan Pharm Inc | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen |
| US6436904B1 (en) * | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| US6544994B2 (en) | 2000-06-07 | 2003-04-08 | Eprov Ag | Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase |
| US6794506B2 (en) * | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| WO2002008206A1 (en) * | 2000-07-21 | 2002-01-31 | Elan Pharmaceuticals, Inc. | 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors |
| PE20020384A1 (es) | 2000-07-21 | 2002-05-28 | Schering Corp | PEPTIDOS COMO INHIBIDORES DE LA PROTEASA SERINA NS3/NS4a DEL VIRUS DE LA HEPATITIS C |
| TW200307671A (en) * | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| WO2005111020A2 (en) | 2004-04-30 | 2005-11-24 | Elan Pharmaceuticals, Inc. | Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4 |
| MX2007000228A (es) * | 2004-07-08 | 2007-03-30 | Elan Pharm Inc | Antagonistas de vla-4 multivalentes que comprenden porsiones de polietilenglicol. |
| WO2007041270A1 (en) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| AU2006297180A1 (en) * | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| EP1996559A1 (en) | 2006-02-27 | 2008-12-03 | Elan Pharmaceuticals Inc. | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
-
2007
- 2007-02-26 EP EP07757498A patent/EP1996559A1/en not_active Withdrawn
- 2007-02-26 MX MX2008010988A patent/MX2008010988A/es active IP Right Grant
- 2007-02-26 BR BRPI0708331-9A patent/BRPI0708331A2/pt not_active IP Right Cessation
- 2007-02-26 CA CA002643838A patent/CA2643838A1/en not_active Abandoned
- 2007-02-26 AU AU2007220068A patent/AU2007220068B2/en not_active Ceased
- 2007-02-26 MY MYPI20083293 patent/MY151045A/en unknown
- 2007-02-26 EA EA200801906A patent/EA017110B1/ru not_active IP Right Cessation
- 2007-02-26 NZ NZ570679A patent/NZ570679A/en not_active IP Right Cessation
- 2007-02-26 TW TW096106544A patent/TWI389904B/zh not_active IP Right Cessation
- 2007-02-26 KR KR1020087023333A patent/KR20080100271A/ko not_active Ceased
- 2007-02-26 US US11/679,042 patent/US7579466B2/en not_active Expired - Fee Related
- 2007-02-26 WO PCT/US2007/062824 patent/WO2007101165A1/en not_active Ceased
- 2007-02-26 JP JP2008556582A patent/JP5135235B2/ja not_active Expired - Fee Related
- 2007-02-26 CN CN2007800065837A patent/CN101389611B/zh not_active Expired - Fee Related
- 2007-02-27 AR ARP070100812A patent/AR059671A1/es not_active Application Discontinuation
-
2008
- 2008-08-13 IL IL193425A patent/IL193425A/en not_active IP Right Cessation
- 2008-08-22 ZA ZA2008/07188A patent/ZA200807188B/en unknown
- 2008-08-27 EC EC2008008701A patent/ECSP088701A/es unknown
- 2008-08-29 NO NO20083743A patent/NO20083743L/no not_active Application Discontinuation
- 2008-09-11 MA MA31231A patent/MA30318B1/fr unknown
-
2009
- 2009-07-17 US US12/505,383 patent/US7820687B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528296A5 (enExample) | ||
| JP2010526146A5 (enExample) | ||
| JP2011529037A5 (enExample) | ||
| JP2003516979A5 (enExample) | ||
| JP2010526145A5 (enExample) | ||
| CA2614529A1 (en) | Pyridazinone derivatives as thyroid hormone receptor agonists | |
| JP2014502979A5 (enExample) | ||
| JP2006503809A5 (enExample) | ||
| JP2017527578A5 (enExample) | ||
| RU2012132692A (ru) | Новые ингибиторы s-нитрозоглутатионредуктазы | |
| JP2016506387A5 (enExample) | ||
| JP2004538285A5 (enExample) | ||
| JP2007515467A5 (enExample) | ||
| JP2014500322A5 (enExample) | ||
| JP2009543795A5 (enExample) | ||
| JP2007500700A5 (enExample) | ||
| JP2005508368A5 (enExample) | ||
| JP2012527487A5 (enExample) | ||
| JP2017507915A5 (enExample) | ||
| MA33385B1 (fr) | Acide trans-4-[[(5s)-5-[[[3,5-bis (trifluorométhyl) phényl] méthyl] (2-méthyl-2h-tétrazol-5-yl) amino]-2,3,4,5-tétrahydro-7,9-diméthyl-1h-1-benzazépin-1-yl] méthyl]-cyclohexane carboxylique | |
| JP2004525183A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| JP2005521664A5 (enExample) | ||
| JP2008508350A5 (enExample) | ||
| JP2002514623A5 (enExample) |